by admin | Sep 15, 2020 | By Manoranjan Das, Formulary Analytics
The NHS drugs bill is estimated to be £20 billion in 2020/21. This is a massive market for any pharmaceutical company big or small to ignore but same time complex to penetrate. A new innovative drug doesn’t guarantee anyone will buy the medicine. For commercial...
by admin | Jul 15, 2020 | By Greg Higgins, Formulary Analytics
How does Commercial Pharma align to NHS guidance opportunities? Formulary Analytics enables companies to be agile and increasingly aligned with ‘their NHS customers. Non-alignment of your product across formulary and guidance status creates scenarios that reduce...
